SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-023619
Filing Date
2024-02-14
Accepted
2024-02-14 16:08:06
Documents
1
Group Members
PARADIGM BIOCAPITAL ADVISORS GP LLCPARADIGM BIOCAPITAL INTERNATIONAL FUND LTD.SENAI ASEFAW, M.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm245955d1_sc13ga.htm SC 13G/A 59496
  Complete submission text file 0001104659-24-023619.txt   61286
Mailing Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 646-970-2123
Paradigm Biocapital Advisors LP (Filed by) CIK: 0001855655 (see all company filings)

IRS No.: 851451055 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma, Inc. (Subject) CIK: 0001990550 (see all company filings)

IRS No.: 932892120 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94206 | Film No.: 24637992
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)